Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $2.45 Million - $3.74 Million
20,452 Added 8.69%
255,762 $32.2 Million
Q1 2024

May 10, 2024

SELL
$170.78 - $208.42 $10.1 Million - $12.3 Million
-58,912 Reduced 20.02%
235,310 $43.3 Million
Q4 2023

Feb 09, 2024

BUY
$114.17 - $185.35 $5.68 Million - $9.22 Million
49,727 Added 20.34%
294,222 $52.9 Million
Q3 2023

Nov 13, 2023

SELL
$138.78 - $176.51 $3.68 Million - $4.68 Million
-26,510 Reduced 9.78%
244,495 $38.9 Million
Q2 2023

Aug 11, 2023

BUY
$138.42 - $180.31 $3.93 Million - $5.12 Million
28,401 Added 11.71%
271,005 $38.3 Million
Q1 2023

May 12, 2023

BUY
$154.26 - $198.1 $6.44 Million - $8.27 Million
41,734 Added 20.78%
242,604 $40.8 Million
Q4 2022

Feb 13, 2023

BUY
$162.42 - $220.56 $5.62 Million - $7.64 Million
34,622 Added 20.83%
200,870 $34 Million
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $10.8 Million - $17.3 Million
-67,378 Reduced 28.84%
166,248 $31.1 Million
Q2 2022

Aug 12, 2022

BUY
$140.68 - $188.02 $12.4 Million - $16.6 Million
88,257 Added 60.71%
233,626 $37.9 Million
Q1 2022

May 16, 2022

BUY
$161.19 - $257.96 $23.4 Million - $37.5 Million
145,369 New
145,369 $27.3 Million
Q2 2021

Aug 10, 2021

SELL
$165.87 - $220.95 $9.39 Million - $12.5 Million
-56,598 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$180.37 - $226.26 $4.7 Million - $5.89 Million
-26,040 Reduced 31.51%
56,598 $11 Million
Q4 2020

Feb 12, 2021

SELL
$148.08 - $206.57 $498,289 - $695,108
-3,365 Reduced 3.91%
82,638 $15.8 Million
Q3 2020

Nov 13, 2020

SELL
$122.51 - $158.27 $18.6 Million - $24.1 Million
-152,100 Reduced 63.88%
86,003 $12.7 Million
Q2 2020

Aug 13, 2020

SELL
$94.33 - $140.48 $8.5 Million - $12.7 Million
-90,081 Reduced 27.45%
238,103 $29.4 Million
Q1 2020

May 14, 2020

BUY
$84.96 - $109.14 $8.78 Million - $11.3 Million
103,300 Added 45.93%
328,184 $31.7 Million
Q4 2019

Feb 13, 2020

BUY
$73.84 - $93.08 $16.6 Million - $20.9 Million
224,884 New
224,884 $20.8 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.71B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.